JPH0769904A - Leukocyte-removing filter - Google Patents

Leukocyte-removing filter

Info

Publication number
JPH0769904A
JPH0769904A JP5243668A JP24366893A JPH0769904A JP H0769904 A JPH0769904 A JP H0769904A JP 5243668 A JP5243668 A JP 5243668A JP 24366893 A JP24366893 A JP 24366893A JP H0769904 A JPH0769904 A JP H0769904A
Authority
JP
Japan
Prior art keywords
layer
leukocyte
fiber
bulk density
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5243668A
Other languages
Japanese (ja)
Inventor
Shinji Ono
真二 大野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissho Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissho Corp filed Critical Nissho Corp
Priority to JP5243668A priority Critical patent/JPH0769904A/en
Publication of JPH0769904A publication Critical patent/JPH0769904A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To prepare a leukocyte removing filter capable of removing leukocyte in blood at a high ratio without lowering the blood flow rate. CONSTITUTION:This leukocyte removing filter is composed of a three-layer fiber aggregate packed in a housing. The 1st layer to collect coagulum particles larger than leukocyte and prevent the clogging of the 2nd layer has a fiber diameter of 10-20mum and a bulk density of 0.15-0.2g/cm<3>, the 2nd layer to collect small particles comparable to leukocyte has a fiber diameter of 4-10mum and a bulk density of 0.07-0.17g/cm<3> and the 3rd layer to remove leukocyte at a high ratio and recover erythrocyte has a fiber diameter of 1-4mum and a bulk density of 0.05-0.15g/cm<3>. A fiber aggregate having an average pore diameter of 80-300mum (preferably a mesh of 30-500mum thick) is inserted as a substrate between the 1st layer and the 2nd layer. The substrate inserted between the 1st and the 2nd layers disperses the blood flow direction in the 1st layer and enables the maintenance of the blood flow rate.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は血液及び体液中の白血球
を除去するフイルターに関する。
TECHNICAL FIELD The present invention relates to a filter for removing leukocytes in blood and body fluids.

【0002】[0002]

【従来の技術】頻回輸血患者の治療において、発熱・悪
寒・掻瘍等の症状を示す非溶血性発熱反応を予防するた
めに白血球除去血液製剤を輸血して症状の改善すること
は広く知られている。
2. Description of the Related Art In the treatment of frequent transfusion patients, it is widely known that leukocyte-removed blood products are transfused to improve non-hemolytic fever reactions that show symptoms such as fever, chills, and scars. Has been.

【0003】通常、血液400cc中には109 個レベ
ルの白血球が存在し、その血液を輸血された患者は抗H
LA抗体を産生して非溶血性発熱反応を呈する。血液中
の白血球の99.9%を除去すると、白血球数は上記単
位量において106 個レベルに低下し、非溶血性発熱反
応は予防される。
Normally, there are 10 9 white blood cells in 400 cc of blood, and patients transfused with the blood have anti-H
It produces LA antibody and exhibits a non-hemolytic fever reaction. When 99.9% of leukocytes in the blood are removed, the leukocyte count is lowered to the level of 10 6 in the above unit dose, and the non-hemolytic fever reaction is prevented.

【0004】また、輸血後の副作用は血液製剤中の白血
球に起因する同種免疫反応によることが解明されるにつ
れ、同種免疫の誘導を予防するために血液中の白血球を
99.9%以上除去することが要望されている。
Further, as it has been revealed that the side effect after blood transfusion is due to the alloimmune reaction caused by leukocytes in blood products, leukocytes in the blood are removed by 99.9% or more in order to prevent the induction of alloimmune. Is required.

【0005】白血球を除去する方法には、血液成分の比
重差を利用した遠心分離による方法と白血球除去フイル
ターを使用する方法があり、簡便な操作で高い白血球除
去率が得られることから白血球除去フイルターの使用が
普及している。
There are two methods for removing leukocytes: a method by centrifugation utilizing the difference in specific gravity of blood components and a method using a leukocyte removal filter. Since a high leukocyte removal rate can be obtained by a simple operation, the leukocyte removal filter is available. The use of is widespread.

【0006】白血球除去フイルターはポリエステル等の
疎水性繊維からなる極細繊維不織布や多孔質体をハウジ
ングに充填したもので、白血球は繊維表面に捕捉吸着し
て除去される。
The leukocyte-removing filter is one in which a housing is filled with an ultrafine fiber nonwoven fabric made of a hydrophobic fiber such as polyester or a porous body, and leukocytes are removed by being trapped and adsorbed on the fiber surface.

【0007】白血球を高率で除去するためには繊維集合
体中の繊維表面積を大きくすることが好ましく、不織布
の体積が同じであれば、不織布中の繊維径の小さい不織
布の方が繊維表面積は大きくなり、同じ繊維径の不織布
では嵩密度を高くして繊維間隔を小さくするほど繊維表
面積は大きくなる。
In order to remove leukocytes at a high rate, it is preferable to increase the fiber surface area in the fiber assembly, and if the volume of the non-woven fabric is the same, the non-woven fabric having a smaller fiber diameter has a smaller fiber surface area. In a non-woven fabric having the same fiber diameter, the larger the bulk density and the smaller the fiber spacing, the larger the fiber surface area.

【0008】血液製剤中には赤血球・白血球・血小板の
ような血球成分や血漿、凝集物が存在し、凝集物による
極細繊維不織布の閉塞を少なくするために、まず、径の
大きい凝集物をプレフイルター層で除去し、次いで、白
血球をメインフイルター層で除去する2層構造のフイル
ターが提案されている。これは、繊維径の大きい繊維集
合体を繊維径の小さい繊維集合体の上層に配置し、メイ
ンフイルターの目詰まりを少なくすることを目的として
いるが、白血球と同サイズの10〜20μmの凝集物を
除去するには十分ではなく、Ht値の高い血液では瀘過
時間の長くなる欠点を有する。
Blood products contain blood cell components such as red blood cells, white blood cells, and platelets, plasma, and agglomerates. First, in order to reduce clogging of the ultrafine fiber nonwoven fabric due to the agglomerates, the agglomerates with a large diameter are first A two-layer filter has been proposed in which leukocytes are removed by a filter layer and then white blood cells are removed by a main filter layer. This aims to reduce the clogging of the main filter by arranging the fiber aggregate having a large fiber diameter in the upper layer of the fiber aggregate having a small fiber diameter, but the aggregate of 10 to 20 μm having the same size as the white blood cells. It is not enough to remove the erythrocyte, and blood having a high Ht value has a defect that the filtration time becomes long.

【0009】また、プレフイルター層を補強した3〜4
層構造にしてメインフイルター層の閉塞を防ぐことが提
案されている(特開平1−236064号)。これは各
層の繊維径と繊維間隔の範囲を限定して、凝集物の大き
い径のものから捕捉されるものであり、2層構造と比較
するとメインフイルター層を閉塞する頻度は少なくなる
が、上層から徐々に目詰まりすることに変わりのないこ
とから未だ技術的に解決されていない。
In addition, 3 to 4 in which the prefilter layer is reinforced
It has been proposed to prevent the main filter layer from being clogged with a layered structure (Japanese Patent Laid-Open No. 1-236064). This is because the range of the fiber diameter and the fiber interval of each layer is limited, and the larger diameter of the agglomerate is captured, and the frequency of closing the main filter layer is less than that of the two-layer structure. Since there is no change in that it gradually becomes clogged, it has not been technically solved yet.

【0010】[0010]

【発明が解決しようとする課題】本発明は疎水性繊維か
らなる繊維集合体を使用した白血球除去フイルターの問
題点を改良して、血液中の白血球を効率的に除去するフ
イルターを提供することを目的とする。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a filter for efficiently removing leukocytes in blood by improving the problems of the leukocyte removal filter using a fiber assembly composed of hydrophobic fibers. To aim.

【0011】[0011]

【課題を解決するための手段及び作用】本発明は、ハウ
ジングに充填される繊維集合体であって、該集合体は、
第1層が繊維径10〜20μm、嵩密度0.15〜0.
25g/立方センチ、第2層が繊維径4〜10μm、嵩
密度0.07〜0.17g/立方センチであり、第3層
が繊維径1〜4μm、嵩密度0.05〜0.15g/立
方センチであって、第1層と第2層の間に支持体として
平均孔径80〜300μmの繊維集合体を配置したこと
を特徴とする白血球除去フイルターを要旨とする。
SUMMARY OF THE INVENTION The present invention is a fiber assembly filled in a housing, the assembly comprising:
The first layer has a fiber diameter of 10 to 20 μm and a bulk density of 0.15 to 0.
25 g / cubic centimeter, the second layer has a fiber diameter of 4 to 10 μm and a bulk density of 0.07 to 0.17 g / cubic centimeter, and the third layer has a fiber diameter of 1 to 4 μm and a bulk density of 0.05 to 0.15 g / A gist of a leukocyte-removing filter characterized in that a fiber assembly having a cubic centimeter and an average pore diameter of 80 to 300 μm is arranged as a support between the first layer and the second layer.

【0012】本発明において、繊維集合体は繊維と繊維
が互いに絡み合い連続した共有空間を多数保持している
集合体であり、多孔質体・不織布・織布・メツシユ等の
形態が挙げられる。
In the present invention, the fiber assembly is an assembly in which fibers are entangled with each other and hold a large number of continuous shared spaces, and examples thereof include forms such as porous bodies, non-woven fabrics, woven fabrics and meshes.

【0013】繊維集合体にはポリエステル・ポリプロピ
レン・ポリエチレン・ポリテトラフルオロエチレン等の
疎水性繊維を使用することが好ましい。
It is preferable to use hydrophobic fibers such as polyester, polypropylene, polyethylene and polytetrafluoroethylene for the fiber assembly.

【0014】使用にあたり、本発明で作られた白血球除
去フイルターに血液を流す方向は、ハウジング内の第1
層の繊維集合体から第2・第3層の繊維集合体に向かっ
て流れるようにする。
In use, the direction of flowing blood through the leukocyte removal filter made according to the present invention is the first in the housing.
Flow from the layer fiber assembly toward the second and third layer fiber assemblies.

【0015】本発明における第1層の繊維径及び嵩密度
は、第2層の目詰まりを防ぎ、白血球より大きい凝集物
を捕捉するために決められたものである。
The fiber diameter and bulk density of the first layer in the present invention are determined to prevent clogging of the second layer and capture aggregates larger than white blood cells.

【0016】本発明における第2層の繊維径及び嵩密度
は、白血球と同サイズの微小凝集物を捕捉するために決
められたものである。
The fiber diameter and bulk density of the second layer in the present invention are determined in order to capture microaggregates of the same size as white blood cells.

【0017】本発明における第3層の繊維径及び嵩密度
は、繊維の製造のし易さ、赤血球の目詰まり防止、濃厚
赤血球を通過させた時の平均繊維間間隔の維持のし易さ
から決められたものである。第3層で白血球を高率で除
去して赤血球を回収できる。
The fiber diameter and bulk density of the third layer in the present invention are such that the fiber is easy to manufacture, the red blood cells are prevented from being clogged, and the average interfiber spacing when passing concentrated red blood cells is maintained. It was decided. White blood cells can be collected at a high rate by removing white blood cells in the third layer.

【0018】本発明では、血液中の凝集物及び白血球を
高率で除去するために上記のような3層の繊維集合体を
使用する。
In the present invention, the above-mentioned three-layer fiber assembly is used to remove aggregates and leukocytes in blood at a high rate.

【0019】しかし、凝集物を繊維表面に捕捉除去する
と共に繊維空間を閉塞するという二面性をもつために、
凝集物を数多く除去するにつれて第1層から徐々に目詰
まりして遂には層全体の流量を低下させてしまうことが
判明した。
However, in order to capture and remove the agglomerates on the fiber surface and block the fiber space,
It was found that as the agglomerates were removed in large numbers, the first layer gradually became clogged, eventually reducing the flow rate of the entire layer.

【0020】従って、第1層で目詰まりする箇所が生じ
ても層全体の流量を低下させない方法を検討した結果、
第1層と第2層の間に支持体を配置することにより、目
詰まりが少なく流量低下が少ないという効果を得た。
Therefore, as a result of studying a method which does not reduce the flow rate of the entire layer even if a clogging point occurs in the first layer,
By disposing the support between the first layer and the second layer, the effect of less clogging and less decrease in the flow rate was obtained.

【0021】従来法では血液流れ方向を一定にして凝集
物を段階的に捕捉除去する効果をもつが、血液流れ方向
を分散しないために目詰まりする箇所が収束するという
欠点があるのに対し、支持体を配置することにより第1
層の血液流れ方向を分散して血液流量を維持することを
可能にした。
The conventional method has the effect of capturing and removing the aggregates stepwise while keeping the blood flow direction constant, but has the drawback that the clogging points converge because the blood flow direction is not dispersed. First by arranging the support
It was possible to maintain the blood flow by distributing the blood flow direction of the layers.

【0022】第2層と第3層の間に支持体を配置する場
合、第1層で血液流れ方向を分散させる効果はなく第2
層で目詰まりすることから好ましくない。
When a support is arranged between the second layer and the third layer, there is no effect of dispersing the blood flow direction in the first layer, and the second layer is used.
It is not preferable because the layer is clogged.

【0023】本発明において、支持体とは第1層と第2
層の間を仕切る厚さ30〜500μmの薄いフイルター
層をいい、メツシユのような形態が好ましく使用され
る。
In the present invention, the support means the first layer and the second layer.
It refers to a thin filter layer having a thickness of 30 to 500 μm that separates layers, and a mesh-like form is preferably used.

【0024】本発明において、平均孔径とは繊維と繊維
とが直角に交差して形成される空間の大きさをいう。
In the present invention, the average pore size means the size of the space formed by fibers intersecting at right angles.

【0025】平均孔径の測定は次の通りである。TYR
ER社製の標準網を用いて、種々の大きさ(径)の微粒
子を用意する。微粒子の材料は、特定する必要はないが
ポリエチレンやポリ塩化ビニルでよい。次にハウジング
内の繊維集合体が、上記微粒子を通過させるときの微粒
子の最大の径と上記微粒子を通過させないときの微粒子
の最小の径を測定する。上記測定の最大径と最小径の平
均値を繊維集合体の平均孔径とする。
The average pore size is measured as follows. TYR
Fine particles of various sizes (diameters) are prepared using a standard mesh manufactured by ER. The particulate material need not be specified, but may be polyethylene or polyvinyl chloride. Next, the fiber aggregate in the housing measures the maximum diameter of the fine particles when passing the fine particles and the minimum diameter of the fine particles when not passing the fine particles. The average value of the maximum diameter and the minimum diameter of the above measurement is defined as the average pore diameter of the fiber assembly.

【0026】本発明において、第1層と第2層の間に配
置する支持体の平均孔径は80〜300μmの範囲であ
る。これが80μm未満であると支持体の厚さが小さく
なり、血液流量を維持することが困難であり、300μ
mを超えると支持体の厚さが大きくなり偏流を起こすこ
とから好ましくない。
In the present invention, the average pore size of the support disposed between the first layer and the second layer is in the range of 80 to 300 μm. If it is less than 80 μm, the thickness of the support becomes small, and it is difficult to maintain the blood flow rate.
When it exceeds m, the thickness of the support becomes large and a drift occurs, which is not preferable.

【0027】[0027]

【発明の効果】本発明の白血球除去フイルターは血液流
量を損失することなく、血液中の白血球を高率で除去す
る効果を有する。
The leukocyte removal filter of the present invention has the effect of removing leukocytes in blood at a high rate without losing the blood flow rate.

【0028】[0028]

【実施例】本発明の効果を実施例により示す。以下の実
施例及び比較例で、評価項目となる白血球除去率・赤血
球回収率は次式により算定した。 白血球除去率={1−(瀘過後白血球数)/(瀘過前白
血球数)}×100 赤血球回収率=(瀘過後Ht値)/(瀘過前Ht値)×
100
EXAMPLES The effects of the present invention will be shown by examples. In the following examples and comparative examples, leukocyte removal rate and red blood cell recovery rate, which are evaluation items, were calculated by the following formula. Leukocyte removal rate = {1- (white blood cell count after filtration) / (white blood cell count before filtration)} × 100 Red blood cell recovery rate = (Ht value after filtration) / (Ht value before filtration) ×
100

【0029】フイルターを充填させるために、濾過面積
40平方センチ、容量30ccのポリオレフイン製のハ
ウジングを用意した。
In order to fill the filter, a polyolefin housing having a filtration area of 40 cm 2 and a capacity of 30 cc was prepared.

【0030】フイルター材料として、繊維径13μm
で、嵩密度0.2g/立方センチのポリエステル不織布
(以下Aという。)及び繊維径5.5μmで、嵩密度
0.12g/立方センチのポリエステル不織布(以下B
という。)、繊維径1.8μmで、嵩密度0.10g/
立方センチのポリエステル不織布(以下Cという。)と
を、更に、支持体として、平均孔径96μmで厚さ18
0μmのポリエステルメツシユ(以下Dという。)を用
意した。
As a filter material, a fiber diameter of 13 μm
And a polyester non-woven fabric having a bulk density of 0.2 g / cubic centimeter (hereinafter referred to as A) and a polyester non-woven fabric having a fiber diameter of 5.5 μm and a bulk density of 0.12 g / cubic centimeter (hereinafter referred to as B).
Say. ), The fiber diameter is 1.8 μm, and the bulk density is 0.10 g /
Cubic centimeter polyester non-woven fabric (hereinafter referred to as C) is further used as a support, having an average pore diameter of 96 μm and a thickness of 18
A polyester mesh of 0 μm (hereinafter referred to as “D”) was prepared.

【0031】実施例として、A−D−B−Cの順にハウ
ジングに充填し、採血後10日の全血400由来の濃厚
赤血球1単位をノンプライミングで充填し、ヘツド差1
mで不織布の充填順に従って、濾過した。濾過前後の白
血球数及びHt値を測定した結果、白血球除去率が9
9.9%、赤血球回収率が97%であった。また、血液
充填直後から血液バツグが空になるまでの時間を濾過時
間として測定した結果、6分11秒であった。
As an example, the housing is filled in the order of A-D-B-C, 1 unit of concentrated red blood cells derived from whole blood 400 on the 10th day after blood collection is filled without priming, and the head difference is 1
The filtration was performed according to the filling order of the nonwoven fabric at m. As a result of measuring the white blood cell count and Ht value before and after filtration, the white blood cell removal rate was 9%.
It was 9.9% and the red blood cell recovery rate was 97%. In addition, the time from immediately after filling the blood until the blood bag became empty was measured as the filtration time, and was 6 minutes 11 seconds.

【0032】比較例1として、支持体を用いないでA−
B−Cの順にハウジングに充填し、実施例と同様の試験
を行った。その結果、白血球除去率が99.8%、赤血
球回収率が92%、濾過時間が18分35秒であった。
As Comparative Example 1, A- was used without using a support.
The housing was filled in the order of B-C, and the same test as the example was performed. As a result, the leukocyte removal rate was 99.8%, the red blood cell recovery rate was 92%, and the filtration time was 18 minutes and 35 seconds.

【0033】比較例2として、D−A−B−Cの順にハ
ウジングに充填し、実施例と同様の試験を行った。その
結果、白血球除去率が99.9%、赤血球回収率が91
%、濾過時間が10分49秒であった。
As Comparative Example 2, the housing was filled in the order of D-A-B-C, and the same test as that of the example was conducted. As a result, the leukocyte removal rate was 99.9% and the red blood cell recovery rate was 91.
%, The filtration time was 10 minutes 49 seconds.

【0034】比較例3として、A−B−D−Cの順にハ
ウジングに充填し、実施例と同様の試験を行った。その
結果、白血球除去率が99.5%、赤血球回収率が85
%、濾過時間が25分13秒であった。
As Comparative Example 3, the housing was filled in the order of A-B-D-C, and the same test as that of the embodiment was conducted. As a result, the leukocyte removal rate was 99.5% and the red blood cell recovery rate was 85.
%, The filtration time was 25 minutes and 13 seconds.

【0035】以上の結果から分かるように比較例に比
し、実施例は最も短い濾過時間で且つ白血球除去率・赤
血球回収率の優れた結果を得られる。
As can be seen from the above results, in comparison with the comparative example, the example has the shortest filtration time and excellent leukocyte removal rate / erythrocyte recovery rate.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 ハウジングに充填される繊維集合体であ
って、該集合体は、第1層が繊維径10〜20μm、嵩
密度0.15〜0.25g/立方センチ、第2層が繊維
径4〜10μm、嵩密度0.07〜0.17g/立方セ
ンチであり、第3層が繊維径1〜4μm、嵩密度0.0
5〜0.15g/立方センチであって、第1層と第2層
の間に支持体として平均孔径80〜300μmの繊維集
合体を配置したことを特徴とする白血球除去フイルタ
ー。
1. A fiber aggregate filled in a housing, wherein the first layer has a fiber diameter of 10 to 20 μm, a bulk density of 0.15 to 0.25 g / cubic centimeter, and a second layer of fibers. The diameter is 4 to 10 μm, the bulk density is 0.07 to 0.17 g / cubic centimeter, and the third layer has a fiber diameter of 1 to 4 μm and a bulk density of 0.0.
A leukocyte-removing filter, which is 5 to 0.15 g / cm 3 and has a fiber assembly having an average pore diameter of 80 to 300 μm as a support between the first layer and the second layer.
JP5243668A 1993-09-03 1993-09-03 Leukocyte-removing filter Pending JPH0769904A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5243668A JPH0769904A (en) 1993-09-03 1993-09-03 Leukocyte-removing filter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5243668A JPH0769904A (en) 1993-09-03 1993-09-03 Leukocyte-removing filter

Publications (1)

Publication Number Publication Date
JPH0769904A true JPH0769904A (en) 1995-03-14

Family

ID=17107224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5243668A Pending JPH0769904A (en) 1993-09-03 1993-09-03 Leukocyte-removing filter

Country Status (1)

Country Link
JP (1) JPH0769904A (en)

Similar Documents

Publication Publication Date Title
US8496833B2 (en) Leukocyte removal method
JPH03173825A (en) Filter for purifying blood platelet
TWI446939B (en) The filter method for removing the filter material and the blood preparation
EP1582228B2 (en) Method of removing leukocytes, leukocyte-removing filter and utilization thereof
JPH07124255A (en) Leukocyte separation filter and leukocyte remover
JPS639449A (en) Instrument for separating blood component
WO1992004906A1 (en) Leukocyte removal method and leukocyte removal filter system
JPH0663131A (en) Method for selectively removing leucocyte
JP2009529924A (en) Method for removing white blood cells from blood
JPH0213588B2 (en)
JPH0534337A (en) Filter for separating leucocyte
WO1989002304A1 (en) Leucocyte-separating filter
JPS61128979A (en) Blood treatment apparatus
JPH0769904A (en) Leukocyte-removing filter
JP2538751B2 (en) Leukocyte capture and separation device
JP2918595B2 (en) White blood cell separator
JPH0782160A (en) Leukocyte-removing filter
JP2559615B2 (en) Leukocyte capture filter for concentrated red blood cells
JP2503505B2 (en) Leukocyte removal filter
JPH04329965A (en) Selective removal method of leukocyte
JP3601037B2 (en) Leukocyte removal filter
JP4036304B2 (en) Cell capture / recovery method
JPS6326089B2 (en)
JPH11290060A (en) Cell separation filter suitable for recovering cell, cell separation system and separation of cell
JPH0515584A (en) Leucocyte removing filter